IL3 and Parkinson disease: Non‐motor symptoms, such as memory deficits and sleep disorders, are increasingly reported in PD patients.[20] In this study, we primarily focused on the effects of IL‐3 on the motor function of PD mouse models; thus, we chose the pole‐climbing test, open field test, and rotarod test.